OAM
KITE

Oppenheimer Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Oppenheimer Asset Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19
Closed -$3K – 1655
2017
Q3 		$3K Buy
+19
New +$2.65K ﹤0.01% 1612

Oppenheimer Asset Management's KITE Position: Q4 2017 in Review

Oppenheimer Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 19 shares — an estimated $3K sold.

Oppenheimer Asset Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $3K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Oppenheimer Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Oppenheimer Asset Management sold 19 Kite Pharma, Inc. shares in Q4 2017, an estimated $3K.
  • Oppenheimer Asset Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Oppenheimer Asset Management's Kite Pharma, Inc. position peaked at $3K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Oppenheimer Asset Management's 13F filing for Q4 2017, filed 7 Feb 2018.